APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 2

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Histone Deacetylase 2 Market Analysis and Forecast 2026-2032

Report ID 173998690219 December 2025191 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 2 Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 2 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 2 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 2 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Histone Deacetylase 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Histone Deacetylase 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Histone Deacetylase 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Histone Deacetylase 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Histone Deacetylase 2 include 4SC AG, Merck & Co., Inc., GlaxoSmithKline Plc, Yungjin Pharm. Co., Ltd., TetraLogic Pharmaceuticals, Sigma-Tau S.p.A., Rodin Therapeutics, MEI Pharma, Inc. and Italfarmaco S.p.A., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Histone Deacetylase 2, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Histone Deacetylase 2, also provides the sales of main regions and countries. Of the upcoming market potential for Histone Deacetylase 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Histone Deacetylase 2 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Histone Deacetylase 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Histone Deacetylase 2 sales, projected growth trends, production technology, application and end-user industry.

Histone Deacetylase 2 Segment by Company

4SC AG

Merck & Co., Inc.

GlaxoSmithKline Plc

Yungjin Pharm. Co., Ltd.

TetraLogic Pharmaceuticals

Sigma-Tau S.p.A.

Rodin Therapeutics

MEI Pharma, Inc.

Italfarmaco S.p.A.

HitGen LTD

Curis, Inc.

Chipscreen Biosciences Ltd

Acetylon Pharmaceuticals, Inc.

Histone Deacetylase 2 Segment by Type

ACY-957

CS-3158

HG-3001

RCY-1305

Others

Histone Deacetylase 2 Segment by Application

Bladder Cancer

Non-Hodgkin Lymphoma

Colon Cancer

Alopecia

Others

Histone Deacetylase 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Histone Deacetylase 2 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Histone Deacetylase 2 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Histone Deacetylase 2 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Histone Deacetylase 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ACY-957 Major Manufacturers Table 3. CS-3158 Major Manufacturers Table 4. HG-3001 Major Manufacturers Table 5. RCY-1305 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Histone Deacetylase 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Bladder Cancer Major Manufacturers Table 9. Non-Hodgkin Lymphoma Major Manufacturers Table 10. Colon Cancer Major Manufacturers Table 11. Alopecia Major Manufacturers Table 12. Others Major Manufacturers Table 13. Histone Deacetylase 2 Industry Trends Table 14. Histone Deacetylase 2 Industry Drivers Table 15. Histone Deacetylase 2 Industry Opportunities and Challenges Table 16. Histone Deacetylase 2 Industry Restraints Table 17. Global Histone Deacetylase 2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Histone Deacetylase 2 Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Histone Deacetylase 2 Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Histone Deacetylase 2 Revenue Market Share by Region (2021-2026) Table 21. Global Histone Deacetylase 2 Revenue Market Share by Region (2027-2032) Table 22. Global Histone Deacetylase 2 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Histone Deacetylase 2 Sales by Region (2021-2026) & (K Units) Table 24. Global Histone Deacetylase 2 Sales by Region (2027-2032) & (K Units) Table 25. Global Histone Deacetylase 2 Sales Market Share by Region (2021-2026) Table 26. Global Histone Deacetylase 2 Sales Market Share by Region (2027-2032) Table 27. Global Histone Deacetylase 2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Histone Deacetylase 2 Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Histone Deacetylase 2 Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Histone Deacetylase 2 Sales Market Share by Manufacturers (2021-2026) Table 31. Global Histone Deacetylase 2 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Histone Deacetylase 2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Histone Deacetylase 2 Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Histone Deacetylase 2 Manufacturers, Product Type & Application Table 35. Global Histone Deacetylase 2 Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Histone Deacetylase 2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Histone Deacetylase 2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Histone Deacetylase 2 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Histone Deacetylase 2 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Histone Deacetylase 2 Revenue Market Share by Type (2021-2026) Table 42. Global Histone Deacetylase 2 Revenue Market Share by Type (2027-2032) Table 43. Global Histone Deacetylase 2 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Histone Deacetylase 2 Sales by Type (2021-2026) & (K Units) Table 45. Global Histone Deacetylase 2 Sales by Type (2027-2032) & (K Units) Table 46. Global Histone Deacetylase 2 Sales Market Share by Type (2021-2026) Table 47. Global Histone Deacetylase 2 Sales Market Share by Type (2027-2032) Table 48. Global Histone Deacetylase 2 Price by Type (2021-2026) & (US$/Unit) Table 49. Global Histone Deacetylase 2 Price by Type (2027-2032) & (US$/Unit) Table 50. Global Histone Deacetylase 2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Histone Deacetylase 2 Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Histone Deacetylase 2 Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Histone Deacetylase 2 Revenue Market Share by Application (2021-2026) Table 54. Global Histone Deacetylase 2 Revenue Market Share by Application (2027-2032) Table 55. Global Histone Deacetylase 2 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Histone Deacetylase 2 Sales by Application (2021-2026) & (K Units) Table 57. Global Histone Deacetylase 2 Sales by Application (2027-2032) & (K Units) Table 58. Global Histone Deacetylase 2 Sales Market Share by Application (2021-2026) Table 59. Global Histone Deacetylase 2 Sales Market Share by Application (2027-2032) Table 60. Global Histone Deacetylase 2 Price by Application (2021-2026) & (US$/Unit) Table 61. Global Histone Deacetylase 2 Price by Application (2027-2032) & (US$/Unit) Table 62. 4SC AG Company Information Table 63. 4SC AG Business Overview Table 64. 4SC AG Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. 4SC AG Histone Deacetylase 2 Product Portfolio Table 66. 4SC AG Recent Development Table 67. Merck & Co., Inc. Company Information Table 68. Merck & Co., Inc. Business Overview Table 69. Merck & Co., Inc. Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Merck & Co., Inc. Histone Deacetylase 2 Product Portfolio Table 71. Merck & Co., Inc. Recent Development Table 72. GlaxoSmithKline Plc Company Information Table 73. GlaxoSmithKline Plc Business Overview Table 74. GlaxoSmithKline Plc Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Plc Histone Deacetylase 2 Product Portfolio Table 76. GlaxoSmithKline Plc Recent Development Table 77. Yungjin Pharm. Co., Ltd. Company Information Table 78. Yungjin Pharm. Co., Ltd. Business Overview Table 79. Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Product Portfolio Table 81. Yungjin Pharm. Co., Ltd. Recent Development Table 82. TetraLogic Pharmaceuticals Company Information Table 83. TetraLogic Pharmaceuticals Business Overview Table 84. TetraLogic Pharmaceuticals Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. TetraLogic Pharmaceuticals Histone Deacetylase 2 Product Portfolio Table 86. TetraLogic Pharmaceuticals Recent Development Table 87. Sigma-Tau S.p.A. Company Information Table 88. Sigma-Tau S.p.A. Business Overview Table 89. Sigma-Tau S.p.A. Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sigma-Tau S.p.A. Histone Deacetylase 2 Product Portfolio Table 91. Sigma-Tau S.p.A. Recent Development Table 92. Rodin Therapeutics Company Information Table 93. Rodin Therapeutics Business Overview Table 94. Rodin Therapeutics Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Rodin Therapeutics Histone Deacetylase 2 Product Portfolio Table 96. Rodin Therapeutics Recent Development Table 97. MEI Pharma, Inc. Company Information Table 98. MEI Pharma, Inc. Business Overview Table 99. MEI Pharma, Inc. Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. MEI Pharma, Inc. Histone Deacetylase 2 Product Portfolio Table 101. MEI Pharma, Inc. Recent Development Table 102. Italfarmaco S.p.A. Company Information Table 103. Italfarmaco S.p.A. Business Overview Table 104. Italfarmaco S.p.A. Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Italfarmaco S.p.A. Histone Deacetylase 2 Product Portfolio Table 106. Italfarmaco S.p.A. Recent Development Table 107. HitGen LTD Company Information Table 108. HitGen LTD Business Overview Table 109. HitGen LTD Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. HitGen LTD Histone Deacetylase 2 Product Portfolio Table 111. HitGen LTD Recent Development Table 112. Curis, Inc. Company Information Table 113. Curis, Inc. Business Overview Table 114. Curis, Inc. Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Curis, Inc. Histone Deacetylase 2 Product Portfolio Table 116. Curis, Inc. Recent Development Table 117. Chipscreen Biosciences Ltd Company Information Table 118. Chipscreen Biosciences Ltd Business Overview Table 119. Chipscreen Biosciences Ltd Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Chipscreen Biosciences Ltd Histone Deacetylase 2 Product Portfolio Table 121. Chipscreen Biosciences Ltd Recent Development Table 122. Acetylon Pharmaceuticals, Inc. Company Information Table 123. Acetylon Pharmaceuticals, Inc. Business Overview Table 124. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Product Portfolio Table 126. Acetylon Pharmaceuticals, Inc. Recent Development Table 127. North America Histone Deacetylase 2 Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Histone Deacetylase 2 Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Histone Deacetylase 2 Sales by Type (2021-2026) & (K Units) Table 130. North America Histone Deacetylase 2 Sales by Type (2027-2032) & (K Units) Table 131. North America Histone Deacetylase 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 132. North America Histone Deacetylase 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 133. North America Histone Deacetylase 2 Revenue by Application (2021-2026) & (US$ Million) Table 134. North America Histone Deacetylase 2 Revenue by Application (2027-2032) & (US$ Million) Table 135. North America Histone Deacetylase 2 Sales by Application (2021-2026) & (K Units) Table 136. North America Histone Deacetylase 2 Sales by Application (2027-2032) & (K Units) Table 137. North America Histone Deacetylase 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 138. North America Histone Deacetylase 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 139. North America Histone Deacetylase 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Histone Deacetylase 2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. North America Histone Deacetylase 2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. North America Histone Deacetylase 2 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 143. North America Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 144. North America Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 145. North America Histone Deacetylase 2 Sales Price by Country (2021-2026) & (US$/Unit) Table 146. North America Histone Deacetylase 2 Sales Price by Country (2027-2032) & (US$/Unit) Table 147. United States Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 148. Canada Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 149. Europe Histone Deacetylase 2 Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Histone Deacetylase 2 Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Histone Deacetylase 2 Sales by Type (2021-2026) & (K Units) Table 152. Europe Histone Deacetylase 2 Sales by Type (2027-2032) & (K Units) Table 153. Europe Histone Deacetylase 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 154. Europe Histone Deacetylase 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 155. Europe Histone Deacetylase 2 Revenue by Application (2021-2026) & (US$ Million) Table 156. Europe Histone Deacetylase 2 Revenue by Application (2027-2032) & (US$ Million) Table 157. Europe Histone Deacetylase 2 Sales by Application (2021-2026) & (K Units) Table 158. Europe Histone Deacetylase 2 Sales by Application (2027-2032) & (K Units) Table 159. Europe Histone Deacetylase 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 160. Europe Histone Deacetylase 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Europe Histone Deacetylase 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Histone Deacetylase 2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Europe Histone Deacetylase 2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Europe Histone Deacetylase 2 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. Europe Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 166. Europe Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 167. Europe Histone Deacetylase 2 Sales Price by Country (2021-2026) & (US$/Unit) Table 168. Europe Histone Deacetylase 2 Sales Price by Country (2027-2032) & (US$/Unit) Table 169. Germany Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 170. France Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 171. U.K. Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 172. Italy Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 173. Netherlands Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 174. China Histone Deacetylase 2 Revenue by Type (2021-2026) & (US$ Million) Table 175. China Histone Deacetylase 2 Revenue by Type (2027-2032) & (US$ Million) Table 176. China Histone Deacetylase 2 Sales by Type (2021-2026) & (K Units) Table 177. China Histone Deacetylase 2 Sales by Type (2027-2032) & (K Units) Table 178. China Histone Deacetylase 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 179. China Histone Deacetylase 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 180. China Histone Deacetylase 2 Revenue by Application (2021-2026) & (US$ Million) Table 181. China Histone Deacetylase 2 Revenue by Application (2027-2032) & (US$ Million) Table 182. China Histone Deacetylase 2 Sales by Application (2021-2026) & (K Units) Table 183. China Histone Deacetylase 2 Sales by Application (2027-2032) & (K Units) Table 184. China Histone Deacetylase 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 185. China Histone Deacetylase 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 186. Asia Histone Deacetylase 2 Revenue by Type (2021-2026) & (US$ Million) Table 187. Asia Histone Deacetylase 2 Revenue by Type (2027-2032) & (US$ Million) Table 188. Asia Histone Deacetylase 2 Sales by Type (2021-2026) & (K Units) Table 189. Asia Histone Deacetylase 2 Sales by Type (2027-2032) & (K Units) Table 190. Asia Histone Deacetylase 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 191. Asia Histone Deacetylase 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 192. Asia Histone Deacetylase 2 Revenue by Application (2021-2026) & (US$ Million) Table 193. Asia Histone Deacetylase 2 Revenue by Application (2027-2032) & (US$ Million) Table 194. Asia Histone Deacetylase 2 Sales by Application (2021-2026) & (K Units) Table 195. Asia Histone Deacetylase 2 Sales by Application (2027-2032) & (K Units) Table 196. Asia Histone Deacetylase 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 197. Asia Histone Deacetylase 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 198. Asia Histone Deacetylase 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. Asia Histone Deacetylase 2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. Asia Histone Deacetylase 2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. Asia Histone Deacetylase 2 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 202. Asia Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 203. Asia Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 204. Asia Histone Deacetylase 2 Sales Price by Country (2021-2026) & (US$/Unit) Table 205. Asia Histone Deacetylase 2 Sales Price by Country (2027-2032) & (US$/Unit) Table 206. Japan Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 207. South Korea Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 208. India Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 209. Australia Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 210. China Taiwan Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 211. Southeast Asia Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 212. SAMEA Histone Deacetylase 2 Revenue by Type (2021-2026) & (US$ Million) Table 213. SAMEA Histone Deacetylase 2 Revenue by Type (2027-2032) & (US$ Million) Table 214. SAMEA Histone Deacetylase 2 Sales by Type (2021-2026) & (K Units) Table 215. SAMEA Histone Deacetylase 2 Sales by Type (2027-2032) & (K Units) Table 216. SAMEA Histone Deacetylase 2 Sales Price by Type (2021-2026) & (US$/Unit) Table 217. SAMEA Histone Deacetylase 2 Sales Price by Type (2027-2032) & (US$/Unit) Table 218. SAMEA Histone Deacetylase 2 Revenue by Application (2021-2026) & (US$ Million) Table 219. SAMEA Histone Deacetylase 2 Revenue by Application (2027-2032) & (US$ Million) Table 220. SAMEA Histone Deacetylase 2 Sales by Application (2021-2026) & (K Units) Table 221. SAMEA Histone Deacetylase 2 Sales by Application (2027-2032) & (K Units) Table 222. SAMEA Histone Deacetylase 2 Sales Price by Application (2021-2026) & (US$/Unit) Table 223. SAMEA Histone Deacetylase 2 Sales Price by Application (2027-2032) & (US$/Unit) Table 224. SAMEA Histone Deacetylase 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. SAMEA Histone Deacetylase 2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. SAMEA Histone Deacetylase 2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. SAMEA Histone Deacetylase 2 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 228. SAMEA Histone Deacetylase 2 Sales by Country (2021-2026) & (K Units) Table 229. SAMEA Histone Deacetylase 2 Sales by Country (2027-2032) & (K Units) Table 230. SAMEA Histone Deacetylase 2 Sales Price by Country (2021-2026) & (US$/Unit) Table 231. SAMEA Histone Deacetylase 2 Sales Price by Country (2027-2032) & (US$/Unit) Table 232. Brazil Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 233. Argentina Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 234. Chile Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 235. Colombia Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 236. Peru Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 237. Saudi Arabia Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 238. Israel Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 239. UAE Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 240. Turkey Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 241. Iran Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 242. Egypt Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Table 243. Key Raw Materials Table 244. Raw Materials Key Suppliers Table 245. Histone Deacetylase 2 Distributors List Table 246. Histone Deacetylase 2 Customers List Table 247. Research Programs/Design for This Report Table 248. Authors List of This Report Table 249. Secondary Sources Table 250. Primary Sources List of Figures Figure 1. Histone Deacetylase 2 Image Figure 2. Global Histone Deacetylase 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase 2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. ACY-957 Image Figure 5. CS-3158 Image Figure 6. HG-3001 Image Figure 7. RCY-1305 Image Figure 8. Others Image Figure 9. Global Histone Deacetylase 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Histone Deacetylase 2 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Bladder Cancer Image Figure 12. Non-Hodgkin Lymphoma Image Figure 13. Colon Cancer Image Figure 14. Alopecia Image Figure 15. Others Image Figure 16. Global Histone Deacetylase 2 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Histone Deacetylase 2 Revenue (2021-2032) & (US$ Million) Figure 18. Global Histone Deacetylase 2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Histone Deacetylase 2 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Histone Deacetylase 2 Revenue Market Share by Region (2021-2032) Figure 21. Global Histone Deacetylase 2 Sales (2021-2032) & (K Units) Figure 22. Global Histone Deacetylase 2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Histone Deacetylase 2 Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Histone Deacetylase 2 Sales YoY (2021-2032) & (K Units) Figure 25. Europe Histone Deacetylase 2 Sales YoY (2021-2032) & (K Units) Figure 26. China Histone Deacetylase 2 Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Histone Deacetylase 2 Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Histone Deacetylase 2 Sales YoY (2021-2032) & (K Units) Figure 29. Global Histone Deacetylase 2 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Histone Deacetylase 2 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Histone Deacetylase 2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Histone Deacetylase 2 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Histone Deacetylase 2 Revenue Market Share by Type (2021-2032) Figure 35. Global Histone Deacetylase 2 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Histone Deacetylase 2 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Histone Deacetylase 2 Sales Market Share by Type (2021-2032) Figure 38. Global Histone Deacetylase 2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Histone Deacetylase 2 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Histone Deacetylase 2 Revenue Market Share by Application (2021-2032) Figure 41. Global Histone Deacetylase 2 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Histone Deacetylase 2 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Histone Deacetylase 2 Sales Market Share by Application (2021-2032) Figure 44. North America Histone Deacetylase 2 Revenue Share by Type (2021-2032) Figure 45. North America Histone Deacetylase 2 Sales Share by Type (2021-2032) Figure 46. North America Histone Deacetylase 2 Revenue Share by Application (2021-2032) Figure 47. North America Histone Deacetylase 2 Sales Share by Application (2021-2032) Figure 48. North America Histone Deacetylase 2 Revenue Share by Country (2021-2032) Figure 49. North America Histone Deacetylase 2 Sales Share by Country (2021-2032) Figure 50. Europe Histone Deacetylase 2 Revenue Share by Type (2021-2032) Figure 51. Europe Histone Deacetylase 2 Sales Share by Type (2021-2032) Figure 52. Europe Histone Deacetylase 2 Revenue Share by Application (2021-2032) Figure 53. Europe Histone Deacetylase 2 Sales Share by Application (2021-2032) Figure 54. Europe Histone Deacetylase 2 Revenue Share by Country (2021-2032) Figure 55. Europe Histone Deacetylase 2 Sales Share by Country (2021-2032) Figure 56. China Histone Deacetylase 2 Revenue Share by Type (2021-2032) Figure 57. China Histone Deacetylase 2 Sales Share by Type (2021-2032) Figure 58. China Histone Deacetylase 2 Revenue Share by Application (2021-2032) Figure 59. China Histone Deacetylase 2 Sales Share by Application (2021-2032) Figure 60. Asia Histone Deacetylase 2 Revenue Share by Type (2021-2032) Figure 61. Asia Histone Deacetylase 2 Sales Share by Type (2021-2032) Figure 62. Asia Histone Deacetylase 2 Revenue Share by Application (2021-2032) Figure 63. Asia Histone Deacetylase 2 Sales Share by Application (2021-2032) Figure 64. Asia Histone Deacetylase 2 Revenue Share by Country (2021-2032) Figure 65. Asia Histone Deacetylase 2 Sales Share by Country (2021-2032) Figure 66. SAMEA Histone Deacetylase 2 Revenue Share by Type (2021-2032) Figure 67. SAMEA Histone Deacetylase 2 Sales Share by Type (2021-2032) Figure 68. SAMEA Histone Deacetylase 2 Revenue Share by Application (2021-2032) Figure 69. SAMEA Histone Deacetylase 2 Sales Share by Application (2021-2032) Figure 70. SAMEA Histone Deacetylase 2 Revenue Share by Country (2021-2032) Figure 71. SAMEA Histone Deacetylase 2 Sales Share by Country (2021-2032) Figure 72. Histone Deacetylase 2 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Histone Deacetylase 2 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • ACY-957
  • CS-3158
  • HG-3001
  • RCY-1305
  • Others
Applications
  • Bladder Cancer
  • Non-Hodgkin Lymphoma
  • Colon Cancer
  • Alopecia
  • Others
Companies covered
  • 4SC AG
  • Merck & Co., Inc.
  • GlaxoSmithKline Plc
  • Yungjin Pharm. Co., Ltd.
  • TetraLogic Pharmaceuticals
  • Sigma-Tau S.p.A.
  • Rodin Therapeutics
  • MEI Pharma, Inc.
  • Italfarmaco S.p.A.
  • HitGen LTD
  • Curis, Inc.
  • Chipscreen Biosciences Ltd
  • Acetylon Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Histone Deacetylase 2 Market by Type
  3. 1.2.1 Global Histone Deacetylase 2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ACY-957
  5. 1.2.3 CS-3158
  6. 1.2.4 HG-3001
  7. 1.2.5 RCY-1305
  8. 1.2.6 Others
  9. 1.3 Histone Deacetylase 2 Market by Application
  10. 1.3.1 Global Histone Deacetylase 2 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Bladder Cancer
  12. 1.3.3 Non-Hodgkin Lymphoma
  13. 1.3.4 Colon Cancer
  14. 1.3.5 Alopecia
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Histone Deacetylase 2 Market Dynamics
  1. 2.1 Histone Deacetylase 2 Industry Trends
  2. 2.2 Histone Deacetylase 2 Industry Drivers
  3. 2.3 Histone Deacetylase 2 Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase 2 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Histone Deacetylase 2 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Histone Deacetylase 2 Revenue by Region
  3. 3.2.1 Global Histone Deacetylase 2 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Histone Deacetylase 2 Revenue by Region (2021-2026)
  5. 3.2.3 Global Histone Deacetylase 2 Revenue by Region (2027-2032)
  6. 3.2.4 Global Histone Deacetylase 2 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Histone Deacetylase 2 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Histone Deacetylase 2 Sales by Region
  9. 3.4.1 Global Histone Deacetylase 2 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Histone Deacetylase 2 Sales by Region (2021-2026)
  11. 3.4.3 Global Histone Deacetylase 2 Sales by Region (2027-2032)
  12. 3.4.4 Global Histone Deacetylase 2 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Histone Deacetylase 2 Revenue by Manufacturers
  2. 4.1.1 Global Histone Deacetylase 2 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Histone Deacetylase 2 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Histone Deacetylase 2 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Histone Deacetylase 2 Sales by Manufacturers
  6. 4.2.1 Global Histone Deacetylase 2 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Histone Deacetylase 2 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Histone Deacetylase 2 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Histone Deacetylase 2 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Histone Deacetylase 2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Histone Deacetylase 2 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Histone Deacetylase 2 Manufacturers, Product Type & Application
  13. 4.7 Global Histone Deacetylase 2 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Histone Deacetylase 2 Market CR5 and HHI
  16. 4.8.2 2025 Histone Deacetylase 2 Tier 1, Tier 2, and Tier 3
5 Histone Deacetylase 2 Market by Type
  1. 5.1 Global Histone Deacetylase 2 Revenue by Type
  2. 5.1.1 Global Histone Deacetylase 2 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Histone Deacetylase 2 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Histone Deacetylase 2 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Histone Deacetylase 2 Sales by Type
  6. 5.2.1 Global Histone Deacetylase 2 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Histone Deacetylase 2 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Histone Deacetylase 2 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Histone Deacetylase 2 Price by Type
6 Histone Deacetylase 2 Market by Application
  1. 6.1 Global Histone Deacetylase 2 Revenue by Application
  2. 6.1.1 Global Histone Deacetylase 2 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Histone Deacetylase 2 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Histone Deacetylase 2 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Histone Deacetylase 2 Sales by Application
  6. 6.2.1 Global Histone Deacetylase 2 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Histone Deacetylase 2 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Histone Deacetylase 2 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Histone Deacetylase 2 Price by Application
7 Company Profiles
  1. 7.1 4SC AG
  2. 7.1.1 4SC AG Company Information
  3. 7.1.2 4SC AG Business Overview
  4. 7.1.3 4SC AG Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 4SC AG Histone Deacetylase 2 Product Portfolio
  6. 7.1.5 4SC AG Recent Developments
  7. 7.2 Merck & Co., Inc.
  8. 7.2.1 Merck & Co., Inc. Company Information
  9. 7.2.2 Merck & Co., Inc. Business Overview
  10. 7.2.3 Merck & Co., Inc. Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co., Inc. Histone Deacetylase 2 Product Portfolio
  12. 7.2.5 Merck & Co., Inc. Recent Developments
  13. 7.3 GlaxoSmithKline Plc
  14. 7.3.1 GlaxoSmithKline Plc Company Information
  15. 7.3.2 GlaxoSmithKline Plc Business Overview
  16. 7.3.3 GlaxoSmithKline Plc Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline Plc Histone Deacetylase 2 Product Portfolio
  18. 7.3.5 GlaxoSmithKline Plc Recent Developments
  19. 7.4 Yungjin Pharm. Co., Ltd.
  20. 7.4.1 Yungjin Pharm. Co., Ltd. Company Information
  21. 7.4.2 Yungjin Pharm. Co., Ltd. Business Overview
  22. 7.4.3 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Yungjin Pharm. Co., Ltd. Histone Deacetylase 2 Product Portfolio
  24. 7.4.5 Yungjin Pharm. Co., Ltd. Recent Developments
  25. 7.5 TetraLogic Pharmaceuticals
  26. 7.5.1 TetraLogic Pharmaceuticals Company Information
  27. 7.5.2 TetraLogic Pharmaceuticals Business Overview
  28. 7.5.3 TetraLogic Pharmaceuticals Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 TetraLogic Pharmaceuticals Histone Deacetylase 2 Product Portfolio
  30. 7.5.5 TetraLogic Pharmaceuticals Recent Developments
  31. 7.6 Sigma-Tau S.p.A.
  32. 7.6.1 Sigma-Tau S.p.A. Company Information
  33. 7.6.2 Sigma-Tau S.p.A. Business Overview
  34. 7.6.3 Sigma-Tau S.p.A. Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sigma-Tau S.p.A. Histone Deacetylase 2 Product Portfolio
  36. 7.6.5 Sigma-Tau S.p.A. Recent Developments
  37. 7.7 Rodin Therapeutics
  38. 7.7.1 Rodin Therapeutics Company Information
  39. 7.7.2 Rodin Therapeutics Business Overview
  40. 7.7.3 Rodin Therapeutics Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Rodin Therapeutics Histone Deacetylase 2 Product Portfolio
  42. 7.7.5 Rodin Therapeutics Recent Developments
  43. 7.8 MEI Pharma, Inc.
  44. 7.8.1 MEI Pharma, Inc. Company Information
  45. 7.8.2 MEI Pharma, Inc. Business Overview
  46. 7.8.3 MEI Pharma, Inc. Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 MEI Pharma, Inc. Histone Deacetylase 2 Product Portfolio
  48. 7.8.5 MEI Pharma, Inc. Recent Developments
  49. 7.9 Italfarmaco S.p.A.
  50. 7.9.1 Italfarmaco S.p.A. Company Information
  51. 7.9.2 Italfarmaco S.p.A. Business Overview
  52. 7.9.3 Italfarmaco S.p.A. Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Italfarmaco S.p.A. Histone Deacetylase 2 Product Portfolio
  54. 7.9.5 Italfarmaco S.p.A. Recent Developments
  55. 7.10 HitGen LTD
  56. 7.10.1 HitGen LTD Company Information
  57. 7.10.2 HitGen LTD Business Overview
  58. 7.10.3 HitGen LTD Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 HitGen LTD Histone Deacetylase 2 Product Portfolio
  60. 7.10.5 HitGen LTD Recent Developments
  61. 7.11 Curis, Inc.
  62. 7.11.1 Curis, Inc. Company Information
  63. 7.11.2 Curis, Inc. Business Overview
  64. 7.11.3 Curis, Inc. Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Curis, Inc. Histone Deacetylase 2 Product Portfolio
  66. 7.11.5 Curis, Inc. Recent Developments
  67. 7.12 Chipscreen Biosciences Ltd
  68. 7.12.1 Chipscreen Biosciences Ltd Company Information
  69. 7.12.2 Chipscreen Biosciences Ltd Business Overview
  70. 7.12.3 Chipscreen Biosciences Ltd Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Chipscreen Biosciences Ltd Histone Deacetylase 2 Product Portfolio
  72. 7.12.5 Chipscreen Biosciences Ltd Recent Developments
  73. 7.13 Acetylon Pharmaceuticals, Inc.
  74. 7.13.1 Acetylon Pharmaceuticals, Inc. Company Information
  75. 7.13.2 Acetylon Pharmaceuticals, Inc. Business Overview
  76. 7.13.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 2 Product Portfolio
  78. 7.13.5 Acetylon Pharmaceuticals, Inc. Recent Developments
8 North America
  1. 8.1 North America Histone Deacetylase 2 Market Size by Type
  2. 8.1.1 North America Histone Deacetylase 2 Revenue by Type (2021-2032)
  3. 8.1.2 North America Histone Deacetylase 2 Sales by Type (2021-2032)
  4. 8.1.3 North America Histone Deacetylase 2 Price by Type (2021-2032)
  5. 8.2 North America Histone Deacetylase 2 Market Size by Application
  6. 8.2.1 North America Histone Deacetylase 2 Revenue by Application (2021-2032)
  7. 8.2.2 North America Histone Deacetylase 2 Sales by Application (2021-2032)
  8. 8.2.3 North America Histone Deacetylase 2 Price by Application (2021-2032)
  9. 8.3 North America Histone Deacetylase 2 Market Size by Country
  10. 8.3.1 North America Histone Deacetylase 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Histone Deacetylase 2 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Histone Deacetylase 2 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Histone Deacetylase 2 Market Size by Type
  2. 9.1.1 Europe Histone Deacetylase 2 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Histone Deacetylase 2 Sales by Type (2021-2032)
  4. 9.1.3 Europe Histone Deacetylase 2 Price by Type (2021-2032)
  5. 9.2 Europe Histone Deacetylase 2 Market Size by Application
  6. 9.2.1 Europe Histone Deacetylase 2 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Histone Deacetylase 2 Sales by Application (2021-2032)
  8. 9.2.3 Europe Histone Deacetylase 2 Price by Application (2021-2032)
  9. 9.3 Europe Histone Deacetylase 2 Market Size by Country
  10. 9.3.1 Europe Histone Deacetylase 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Histone Deacetylase 2 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Histone Deacetylase 2 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Histone Deacetylase 2 Market Size by Type
  2. 10.1.1 China Histone Deacetylase 2 Revenue by Type (2021-2032)
  3. 10.1.2 China Histone Deacetylase 2 Sales by Type (2021-2032)
  4. 10.1.3 China Histone Deacetylase 2 Price by Type (2021-2032)
  5. 10.2 China Histone Deacetylase 2 Market Size by Application
  6. 10.2.1 China Histone Deacetylase 2 Revenue by Application (2021-2032)
  7. 10.2.2 China Histone Deacetylase 2 Sales by Application (2021-2032)
  8. 10.2.3 China Histone Deacetylase 2 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Histone Deacetylase 2 Market Size by Type
  2. 11.1.1 Asia Histone Deacetylase 2 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Histone Deacetylase 2 Sales by Type (2021-2032)
  4. 11.1.3 Asia Histone Deacetylase 2 Price by Type (2021-2032)
  5. 11.2 Asia Histone Deacetylase 2 Market Size by Application
  6. 11.2.1 Asia Histone Deacetylase 2 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Histone Deacetylase 2 Sales by Application (2021-2032)
  8. 11.2.3 Asia Histone Deacetylase 2 Price by Application (2021-2032)
  9. 11.3 Asia Histone Deacetylase 2 Market Size by Country
  10. 11.3.1 Asia Histone Deacetylase 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Histone Deacetylase 2 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Histone Deacetylase 2 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Histone Deacetylase 2 Market Size by Type
  2. 12.1.1 SAMEA Histone Deacetylase 2 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Histone Deacetylase 2 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Histone Deacetylase 2 Price by Type (2021-2032)
  5. 12.2 SAMEA Histone Deacetylase 2 Market Size by Application
  6. 12.2.1 SAMEA Histone Deacetylase 2 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Histone Deacetylase 2 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Histone Deacetylase 2 Price by Application (2021-2032)
  9. 12.3 SAMEA Histone Deacetylase 2 Market Size by Country
  10. 12.3.1 SAMEA Histone Deacetylase 2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Histone Deacetylase 2 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Histone Deacetylase 2 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Histone Deacetylase 2 Value Chain Analysis
  2. 13.1.1 Histone Deacetylase 2 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Histone Deacetylase 2 Production Mode & Process
  6. 13.2 Histone Deacetylase 2 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Histone Deacetylase 2 Distributors
  9. 13.2.3 Histone Deacetylase 2 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst